Abstract
Maternal thyrotoxicosis complicates approximately 0.2% of pregnancies. Simultaneous occurrence of maternal and fetal thyrotoxicosis during labor is rare, and control of maternal tachycardia and hypertension, as well as fetal manifestations of thyrotoxicosis, are cornerstones of management. An 18- year-old nulliparous female at 33 weeks gestational age presented in labor with thyrotoxicosis. Fetal tachycardia was present as well. Labetalol therapy resulted in a decrease in maternal pulse and blood pressure, and resolution of fetal tachycardia. Vaginal delivery occurred. Subsequent evaluation demonstrated neonatal thyrotoxicosis and high maternal titers of thyroid- stimulating immunoglobulin. In conclusion, labetalol was beneficial in the treatment of maternal and fetal thyrotoxicosis during labor.
| Original language | English |
|---|---|
| Pages (from-to) | 795-796 |
| Number of pages | 2 |
| Journal | Thyroid |
| Volume | 8 |
| Issue number | 9 |
| State | Published - 1998 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Endocrinology
Cite this
Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. / Bowman, Mary L.; Bergmann, Michele; Smith, Jr., James.
In: Thyroid, Vol. 8, No. 9, 1998, p. 795-796.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis
AU - Bowman, Mary L.
AU - Bergmann, Michele
AU - Smith, Jr., James
PY - 1998
Y1 - 1998
N2 - Maternal thyrotoxicosis complicates approximately 0.2% of pregnancies. Simultaneous occurrence of maternal and fetal thyrotoxicosis during labor is rare, and control of maternal tachycardia and hypertension, as well as fetal manifestations of thyrotoxicosis, are cornerstones of management. An 18- year-old nulliparous female at 33 weeks gestational age presented in labor with thyrotoxicosis. Fetal tachycardia was present as well. Labetalol therapy resulted in a decrease in maternal pulse and blood pressure, and resolution of fetal tachycardia. Vaginal delivery occurred. Subsequent evaluation demonstrated neonatal thyrotoxicosis and high maternal titers of thyroid- stimulating immunoglobulin. In conclusion, labetalol was beneficial in the treatment of maternal and fetal thyrotoxicosis during labor.
AB - Maternal thyrotoxicosis complicates approximately 0.2% of pregnancies. Simultaneous occurrence of maternal and fetal thyrotoxicosis during labor is rare, and control of maternal tachycardia and hypertension, as well as fetal manifestations of thyrotoxicosis, are cornerstones of management. An 18- year-old nulliparous female at 33 weeks gestational age presented in labor with thyrotoxicosis. Fetal tachycardia was present as well. Labetalol therapy resulted in a decrease in maternal pulse and blood pressure, and resolution of fetal tachycardia. Vaginal delivery occurred. Subsequent evaluation demonstrated neonatal thyrotoxicosis and high maternal titers of thyroid- stimulating immunoglobulin. In conclusion, labetalol was beneficial in the treatment of maternal and fetal thyrotoxicosis during labor.
UR - http://www.scopus.com/inward/record.url?scp=0031761629&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031761629&partnerID=8YFLogxK
M3 - Article
VL - 8
SP - 795
EP - 796
JO - Thyroid
JF - Thyroid
SN - 1050-7256
IS - 9
ER -